In fiscal 2025, which ended Sep 30, 2025, BNB Plus Corp. used $12.2 million of cash from operations. It spent $313,121 on capital expenditures. Free cash flow was negative, at -$12.6 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Sep 30, 2025
|
FY 2024
Sep 30, 2024
|
FY 2023
Sep 30, 2022
|
FY 2021
Sep 30, 2021
|
FY 2020
Sep 30, 2020
|
FY 2019
Sep 30, 2019
|
FY 2018
Sep 30, 2018
|
FY 2017
Sep 30, 2017
|
FY 2016
Sep 30, 2016
|
FY 2015
Sep 30, 2015
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Depreciation and amortization |
0
-24.2%
|
0
-11.2%
|
0
-68.2%
|
1
+0.0%
|
1
+195.5%
|
0
-26.8%
|
0
-28.7%
|
1
-13.5%
|
1
-10.4%
|
1
+44.0%
|
0
+10.9%
|
| Stock-based compensation |
1
+1000.0%
|
0
-82.2%
|
1
-44.6%
|
3
+0.0%
|
2
+66.6%
|
1
-11.3%
|
1
-16.8%
|
1
-58.4%
|
3
+59.8%
|
2
-49.3%
|
4
+97.8%
|
| Operating cash flow |
-12
|
-12
|
—
|
—
|
—
|
-11
-62.4%
|
-7
+0.8%
|
-7
+7.5%
|
-7
+24.4%
|
-10
-42.1%
|
-7
+18.2%
|
| Investing | |||||||||||
| Capital expenditures |
—
|
0
-23.2%
|
0
+420.0%
|
0
+0.0%
|
3
+139.6%
|
1
+1477.3%
|
0
-74.6%
|
0
+82.9%
|
0
-78.4%
|
1
+91.4%
|
0
+53.1%
|
| Investing cash flow |
-3
|
-0
|
—
|
—
|
—
|
—
|
—
|
—
|
-0
+81.3%
|
-1
+63.5%
|
-2
-831.5%
|
| Financing | |||||||||||
| Financing cash flow |
13
+72.9%
|
8
-39.9%
|
13
-26.1%
|
18
|
15
-24.3%
|
19
+233.4%
|
6
-0.9%
|
6
-3.6%
|
6
-22.2%
|
8
-47.8%
|
15
+298.0%
|
| Change in cash | |||||||||||
| Net change in cash |
-2
+69.7%
|
-5
-560.0%
|
-1
+90.1%
|
9
+0.0%
|
-1
-117.0%
|
7
+756.7%
|
-1
|
—
|
—
|
—
|
—
|
| Free cash flow |
—
|
-13
|
—
|
—
|
—
|
-12
-76.2%
|
-7
+3.5%
|
-7
+5.8%
|
-8
+27.9%
|
-11
-44.4%
|
-7
+16.3%
|
| Per share | |||||||||||
| Free cash flow per share |
—
|
-24.25
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Ratios | |||||||||||
| Free cash flow margin |
—
|
-587.56%
|
—
|
—
|
—
|
-631.98%
|
-128.58%
|
-184.03%
|
-160.48%
|
-252.47%
|
-81.23%
|
| Capital expenditures to revenue |
—
|
14.65%
|
19.30%
|
2.69%
|
28.23%
|
55.07%
|
1.25%
|
6.81%
|
3.06%
|
16.07%
|
3.90%
|
| Stock-based compensation to revenue |
50.82%
|
4.77%
|
27.08%
|
13.86%
|
18.48%
|
51.83%
|
20.95%
|
34.75%
|
68.56%
|
48.70%
|
44.65%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- BNBX (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Stony Brook, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 744452
- Former names
- APPLIED DNA SCIENCES INC (until Nov 10, 2025); PROHEALTH MEDICAL TECHNOLOGIES INC (until Dec 18, 2002); DCC ACQUISITION CORP (until May 4, 2001); DATALINK CAPITAL CORP/TX/ (until Feb 8, 1999)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.